Insider · CIK 0001292341
Nicolas H Roelofs PHD
Files at SEER (Seer, Inc.). First filing -, latest -.
In brief
Nicolas H Roelofs PHD files SEC Form 4 as director at SEER (Seer, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nicolas H Roelofs PHD has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | SEER Seer, Inc. | AGrant or award Class A Common Stock | +16,500 | $0.00 | $0 | 91,496 | Jul 30, 2026 |
| Jul 28, 2026 | SEER Seer, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jul 30, 2026 |
| Jul 7, 2025 | SEER Seer, Inc. | AGrant or award Class A Common Stock | +17,083 | $0.00 | $0 | 74,996 | Jul 9, 2025 |
| Jul 7, 2025 | SEER Seer, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,416 | $0.00 | $0 | 25,416 | Jul 9, 2025 |
Questions about Nicolas H Roelofs PHD
Answered from the filings on this page, as of the latest one.
Is Nicolas H Roelofs PHD buying or selling?
Nicolas H Roelofs PHD has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nicolas H Roelofs PHD's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicolas H Roelofs PHD has 0.
Where does Nicolas H Roelofs PHD file Form 4?
Nicolas H Roelofs PHD has filed Form 4 at SEER (Seer, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.